SCHEMBL2541083

SCHEMBL2541083

Cc1ccc(S(=O)(=O)OC[C@H](O)c2ccccc2Cl)cc1

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.43
CYP2C19 P33261 1/20 0.43
ADRB2 P07550 2/20 0.41
ADRB1 P08588 2/20 0.41
AOC3 Q16853 1/20 0.41
PKM P14618 1/20 0.41
CYP2D6 P10635 1/20 0.40
NFKB1 P19838 1/20 0.40
HIF1A Q16665 1/20 0.40
ALDH1A1 P00352 1/20 0.40
DHODH Q02127 1/20 0.40
TP53 P04637 1/20 0.40
BLM P54132 1/20 0.40
LMNA P02545 1/20 0.39
HTT P42858 1/20 0.39
CASP1 P29466 1/20 0.39
KMT2A Q03164 1/20 0.39
POLB P06746 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25345455 1.00 CYP1A2 (0.43) CYP1A2CYP2C19ADRB2ADRB1AOC3
SCHEMBL2537530 0.84 DHODH (0.40) CYP1A2CYP2C19PKMCYP2D6ALDH1A1
SCHEMBL2544318 0.84 KMT2A (0.46) PKMALDH1A1DHODHLMNAHTT
SCHEMBL2545829 0.80 PKM (0.53) PKMCYP2D6ALDH1A1DHODHLMNA
SCHEMBL1206501 0.80 PKM (0.53) PKMCYP2D6ALDH1A1DHODHLMNA
SCHEMBL4920359 0.80 PKM (0.53) PKMCYP2D6ALDH1A1DHODHLMNA
SCHEMBL2536099 0.80 ADRB2 (0.47) CYP1A2CYP2C19ADRB2ADRB1AOC3
SCHEMBL2539995 0.78 PKM (0.44) CYP2C19PKMCYP2D6ALDH1A1DHODH
SCHEMBL6980265 0.78 PKM (0.44) CYP2C19PKMCYP2D6ALDH1A1DHODH
SCHEMBL2545371 0.78 UTS2R (0.42) PKMALDH1A1TP53LMNAHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250002466-A1 PROCESS FOR THE PREPARATION OF CENOBAMATE ANND INTERMEDIATES THEREOF METROCHEM API PVT LTD 2025-01-02 US disclosed
WO-2023152711-A1 PROCESS FOR THE PREPARATION OF CENOBAMATE AND INTERMEDIATES THEREOF METROCHEM API PVT LTD (IN) 2023-08-17 WO disclosed
US-8044245-B2 Method for the preparation of optically active 2-sulfonyloxy-1-phenylethanol derivatives KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2011-10-25 US disclosed
US-20100063317-A1 METHOD FOR THE PREPARATION OF OPTICALLY ACTIVE 2-SULFONYLOXY-1-PHENYLETHANOL DERIVATIVES KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2010-03-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250002466-A1 PROCESS FOR THE PREPARATION OF CENOBAMATE ANND INTERMEDIATES THEREOF TALDO1, AURKB, PGD CYP1A2 536/4885CYP2C19 531/4885ADRB2 3203/4885
US-20100063317-A1 METHOD FOR THE PREPARATION OF OPTICALLY ACTIVE 2-SULFONYLOXY-1-PHENYLETHANOL DERIVATIVES FOXO1, ENO1, SULT1A1 CYP1A2 45/4885CYP2C19 182/4885ADRB2 156/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.